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Abstract
Obese dogs seem to have a different gut microbiome (GM) composition compared to lean dogs, and in
humans, GM composition may negatively impact the ability to lose weight in some individuals. The purpose of
this study was to investigate the interaction between exercise, weight-loss and the composition of GM in dogs.
Eighteen obese pet dogs were recruited for a 12-week weight-loss intervention. All dogs were fed restrictively
with a commercial high-protein/high-fibre dry diet, and eight of these dogs were enrolled in an exercise pro-
gram in addition to the diet intervention. Faecal samples were collected and the dogs were weighed at week 0,
week 6 and week 12. GM composition was determined using MiSeq-based tag-encoded 16S rRNA gene high-
throughput amplicon sequencing, and concentrations of short chain fatty acids (SCFA) by gas-liquid chro-
matography. Total weight loss, food allowance and GM were not changed by exercise inclusion. However,
Megamonas abundance negatively correlated with weight loss rate and Ruminococcaceae relative abundance
was lower at 12 weeks in dogs with a faster weight loss rate (≥1% per week) compared with slower weight loss
rate (<1% per week) independent of exercise. Acetic and propionic acid concentrations decreased in the dogs
with a faster weight loss rate. Members of Megamonas and Ruminococcaceae produce acetic and propionic
acids and we therefore interpret that having a GM that favour SCFA production may negatively affect weight
loss rate in dogs. Weight loss rate in dogs may be related to the composition of the GM and its production of
metabolites.
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Introduction
Obesity is considered the most common companion
animal nutritional imbalance in developed countries
(German 2006). Studies have shown that obesity in
dogs leads to a shortened life span (Kealy et al.
2002), decreased quality of life as well as an
increased risk of diseases such as degenerative joint
diseases, neoplasia and respiratory dysfunction
(Alenza et al. 2000; Kealy et al. 2002; Bach et al.
2007). Treatment of obesity is in theory a simple
combination of restricting intake of calories and, if
possible, increasing energy expenditure. However, in
reality weight loss trials, even when successful, rarely
sustain long-term effects (Fildes et al. 2015; German
et al. 2015). Research in the field of obesity has
uncovered a complicated network of factors con-
tributing to weight gain and resistance to weight loss,
including diet, genes, and gut microbiota (GM). Fur-
thermore, the swift increase in the occurrence of
obesity during recent decades makes a single/simple
genetic cause highly unlikely, and instead favours the
impact of combinations of environmental factors
(Ajslev et al. 2015). Recent studies in animal models
and humans have underlined the importance of the
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GM composition in both influencing the amount of
energy extracted from the diet as well as affecting
the risk of obesity and development of metabolic dis-
ease (Ley et al. 2006; Handl et al. 2013; Pedersen
et al. 2016).
In humans, several studies have investigated the
GM compositional differences between obese and
lean individuals and the effect of weight loss (Ley
et al. 2006; Duncan et al. 2008; Santacruz et al. 2009;
Cotillard et al. 2013). However, it remains difficult to
separate the effects of weight loss from energy
restriction and altered macronutrient composition.
Ley et al. (2006) found the GM differences between
obese and lean humans to be reversible with weight
loss, and the identified changes occurring as a part of
weight loss were not related to the two different diets
used. Subsequent studies failed to repeat this result,
and instead found the GM changes seen with weight
loss in obese humans to be related to the composi-
tion of the weight loss diets (Duncan et al. 2008; San-
tacruz et al. 2009). A possible explanation for these
inconsistencies is that different subpopulations of
obese individuals may respond differently to a speci-
fic weight loss diet (Santacruz et al. 2009; Cotillard
et al. 2013).
In addition to dietary means for achieving weight
loss, exercise supports energy expenditure and influ-
ences the metabolism in a multitude of ways (Lavie
et al. 2015). Evidence from animal models suggests
that exercise may influence the GM composition
(Queipo-Ortu~no et al. 2013). This may also be true
in humans, though data separating the influence of
diet from exercise have not yet been published
(Clarke et al. 2014). Obese and overweight dogs also
seem to differ in their GM composition compared to
lean dogs (Handl et al. 2013). However, to the best
of our knowledge the GM composition of obese pet
dogs during weight loss has not previously been
studied.
This study was conducted to investigate if the GM
composition relates to how effectively dogs lose
weight during a weight loss intervention, and if exer-
cise can influence the GM composition during weight
loss in overweight dogs. Short chain fatty acids analy-
sis was performed to elucidate interactions between
the GM and weight loss rate. The faecal samples
were obtained from dogs participating in a 12-week
weight loss intervention with or without an exercise
program. Results from this intervention have previ-
ously been published regarding effects on body com-
position, immunometabolic parameters, gene
expression and energy expenditure (Larsson et al.
2014; Herrera Uribe et al. 2016; Vitger et al. 2016,
2017).
Methods and material
Dogs and collection of samples
Overweight dogs (n = 18 included in this study) were
recruited through advertisements, pamphlets at the
University Hospital for Companion Animals,
University of Copenhagen, and by referrals from
local primary care practices. Overweight, but other-
wise healthy medium- to large-breed adult dogs
(Body Condition Score ≥ 6, on a scale from 1 to 9
(Laflamme 1997)) with a sedentary life style (defined
as no regular high intensity activity, and only short
and/or low intensity daily walks), were included in a
prospective non-randomized 12-week weight loss
trial. Dogs were considered healthy when they had
no recent history of severe illness, no abnormalities
identified on physical examination and a complete
blood count (CBC) and biochemistry within the lab-
oratory reference interval. None of the included dogs
had previously been enrolled in a weight loss inter-
vention. The study was approved by the Administra-
tive and Ethical Committee at the Department of
Veterinary Clinical and Animal Sciences, University
of Copenhagen, as well as by the Danish Animal
Experimentation Inspectorate (approval No.
2011_561-80). For the entire duration of the study,
all dogs were fed the same commercial low-fat, high-
protein/high fibre, dry diet (Royal Canin Satiety
Support, protein 44.5% of ME, fat 29.7% of ME, car-
bohydrate 25.8% of ME, crude fibre 17.9% of DM,
total dietary fibre 31.4% of DM, Royal Canin,
Aimargues, France). Following inclusion, the dogs
were allocated to either a diet and exercise (FD)
group, or to a diet-only (DO) group solely by owner
preference, as previously described (Vitger et al.
2016). Prior to study start, dogs were weighed and
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had their BCS determined. Physical examination,
blood and urine samples were collected and analysed
to verify that the dogs were healthy. Dual-energy X-
ray absorptiometry (DEXA), scans as well as fat and
muscle biopsy collections were performed at week 0,
6 and 12, and these results have been published pre-
viously (Herrera Uribe et al. 2016; Vitger et al.
2016). The amount of diet to be fed daily to each dog
was calculated, by the use of a purpose-designed
software program (Slimfit, Royal Canin, Aimargues,
France). Dogs were fed 55% of the daily estimated
maintenance energy requirement (MER) (according
to the calculation, 552.3 kJ/kg target
weight0.73[251 kJ/lb target weight0.73]) to achieve a
weight loss rate of approximately 1.5% per week. At
commencement of the program and at fortnightly
visits to the hospital, all dogs were weighed and
adherence to diet and exercise routines were dis-
cussed with the owners. In cases of non-compliance,
– primarily the dog scavenging for food, – measures
to minimize the problem were discussed with the
owner. If needed, adjustments in the amount fed
were made to achieve the targeted weight loss rate.
Dogs that received local or systemic antibiotics dur-
ing the intervention were excluded. Dogs participat-
ing in the exercise program would come to the
hospital for training three times a week. Training
was supervised and consisted of 30 min in the water
treadmill and 30 min on the land-based treadmill.
Moreover, the owners of the dogs in the fitness group
were encouraged to increase their dog’s home exer-
cise by half an hour daily.
At inclusion, prior to introduction of feeding with
the weight loss diet, and subsequently after 6 and
12 weeks faecal samples were collected per rectum,
transferred to a tube, frozen and kept at 80°C until
further analyses.
DNA extraction
The faecal samples were thawed on ice and approxi-
mately 200 mg of sample were weighted into a Fas-
tPrep tube (QBiogene, Carlsbad, CA, USA) for
extracting cellular DNA with QIAamp DNA Stool
Mini Kit (Qiagen, Hilden, Germany) according to
the manufacturer’s standard protocol, but modified
with an initial bead-beating step (FastPrep, FP120).
DNA concentration was measured using Nanodrop
(ND-100, NanoDrop Technologies, Wilmington, DE,
USA). Extracted DNA was stored at 20°C until
further analysis.
PCR amplification, Illumina sequencing
The faecal prokaryotic microbiota composition were
determined using tag-encoded 16S rRNA gene
MiSeq-based (Illumina, San Diego, CA, USA) high
throughput sequencing as previously reported (Pyndt
Jørgensen et al. 2014). In short, the V3-V4 region of
the 16S rRNA gene was amplified by PCR using pri-
mers compatible with the Nextera Index Kit (Illu-
mina). Amplified fragments with adapters and tags
were purified, and quantified prior to Illumina
sequencing.
Short chain fatty acids analysis
Concentrations of the short-chain fatty acids
(SCFAs) acetic, propionic, butyric, isobutyric, valeric
and isovaleric acid, and lactic acid in faecal samples
were quantified by gas chromatography as previously
described (Canibe et al. 2007). Faecal short chain
fatty acid content was analysed for both week 0 and
6 samples for 9 of 12 dogs where enough faecal mat-
ter was available post sequencing. Additionally,
enough faecal matter was available for analysis of
week 0 samples from two dogs and a 6-week sample
from one additional dog. Since changes in feeding
amount was adjusted in several dogs between week 6
and 12, the 12 week samples were not included in
the SCFA analysis to minimize possible interaction
between the feeding ration and weight loss.
Bioinformatics and Statistical analysis
After the conclusion of the intervention, three dogs
(2 FD and 1 DO) were excluded from faecal analyses
as they had received antibiotic treatment during the
intervention. Additionally, two samples were
excluded from the bioinformatics and statistical anal-
ysis of the GM composition due to low DNA concen-
tration (1 week 6 and 1 week 12 sample from two
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different dogs in the DO group), and three samples
due to number of reads being <10 000 reads per sam-
ple (1 week 0, and 1 week 6, sample and 1 week 12
sample from one dog in the FD group). In total 11
dogs (six dogs, 15 samples in the FD group and five
dogs, 16 samples in the DO groups) were included in
the bioinformatic and statistical analysis of the GM
composition (see Fig. S1). The sequencing results
were analysed using the Quantitative Insights Into
Microbial Ecology (QIIME) pipeline (Caporaso
et al. 2010). Principal Coordinate Analysis (PCoA)
plots were generated with the Jackknifed Beta
Diversity workflow (see Fig. S2), and analysis of sim-
ilarities (ANOSIM) was used to evaluate group dif-
ferences between groups using weighted and
unweighted uniFrac distance metrics.
Alpha diversity expressed as an observed species
(sequence similarity 97% OTUs) value was com-
puted for rarefied OTU tables (33 000 reads per sam-
ple) using the alpha rarefaction workflow. Testing on
the differences in alpha diversity was conducted
using t-test employing the non-parametric (Monte
Carlo) method (999 permutations) i.e. implemented
in the compare alpha diversity workflow. Since no
significant changes in the GM composition were
found when comparing the FD and DO groups, the
two groups were merged for the remainder of the
analysis. The 2014 AAHA Weight Management
Guidelines for Dogs and Cats describes a weight loss
rate of 1–2% as desirable (Brooks et al. 2014). To
explore if the weight loss rate during the intervention
related to GM composition, the dogs were divided
into groups based on having a fast weight loss (≥1%
of body weight (BW) per week) or a slow weight loss
(<1% of BW per week). The false discovery rate
(FDR), was calculated to illustrate the expected pro-
portion of Type I errors (represented as q-values in
Tables 1 and 2). The GM composition changes that
were significant over time (week 0, 6 and 12) on a
genus level, when data from both groups (FD and
DO) were pooled together, were then tested for cor-
relation with weight lost, using Spearman correlation.
In addition to the PCoA, a Principal Component
Analysis (PCA) was conducted in MATLAB 2015b
of the rarefied relative abundance OTUs (genus
level) data and SCFA data (see Fig. S3). This was
done to visualize possible clustering patterns of the
fast weight loss compared to the slow weight loss
group relating to the GM as well as the SCFA data.
The first four components were plotted against each
other, as they together accounted for >90% of the
variation in the data. An ANOVA comparing the
SCFA levels at week 0 and week 6 was performed in
R Studio 2015. The ANOVA used to compare the
faecal SCFA concentrations included age as a factor,
as age has previously been found to influence SCFA
concentration in dogs (Gomes et al. 2011).
Results
Three dogs did not complete the intervention, one of
these dogs had a mammary tumour and was reluctant
Table 1. The three most significant differences in gut microbiota (GM), as relative abundance OTUs at genus level, comparing the three time
points week 0–6, week, 0–12 and week 6–12, in dogs (n = 11) during a 12 week weight loss trial (data was analysed using ANOVA, P < 0.05,
in bold, was considered a significant change)
Bacterial genus* P-value False discovery rate q-value
GM change Week 0–6 Sutterella spp. 0.01 0.56
Fusobacterium spp. 0.02 0.42
Megamonas spp. 0.03 0.44
Week 0–12 Megamonas spp. 0.01 0.48
Fusobacterium spp. 0.02 0.36
Sutterella spp. 0.04 0.48
Week 6–12 Parabacteroides spp. 0.14 5.46
Faecalibacterium spp. 0.16 3.20
Unknown (Erysipelotrichaceae spp.) 0.20 2.72
*if unknown genus, (family).
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to exercise, and one dog had signs of lumbar pain
and one dog arthritis. Three additional dogs were
excluded due to having received local or systemic
antibiotics during the intervention. All dogs (n = 12)
lost weight during the intervention (5.55% [2.9–11.3]
at 6 weeks and additionally 6.75% [1.3–12.2] at
12 weeks of initial BW). No adjustments in the
amount fed were made between inclusion and
6 weeks in any of the dogs while adjustments to the
amount of diet being fed was made in seven of the 10
dogs (reduced amount in six and increased amount
in one dog) between week 6 and 12. Of the 11 dogs,
where DNA quality and the number of reads per
sample were adequate, for inclusion in the bioinfor-
matics and statistical analysis of the GM data, five
were Labrador retrievers, two were Australian Shep-
herds and two were mixed breeds, while the remain-
ing dogs were a Bernese Mountain dog, and a Basset
Griffon Vendeen. Characteristics of the 12 dogs
including age, sex, neutering status and weight loss
rate are summarized in Table 3. Prior to inclusion,
the main diet of 10 dogs was various commercial dry
diets, one dog was fed a raw food diet prior to inclu-
sion, and another was fed a mix of commercial dry
diet and table scraps.
Six of the 12 dogs failed to reach the expected
weight loss (1% of BW per week) at 6 weeks and the
amount of diet was therefore reduced at that point.
The daily feeding level was reduced for six of 12 dogs
at 6 weeks of intervention while one of the 12 dogs
reached ideal weight at week 6, and for this dog the
amount of diet fed was adjusted to maintenance level
for week 7–12. There were no obvious differences in
the distribution of breed, age, sex and neutering sta-
tus between the dogs that had a slow weight loss rate
(<1% of BW per week), with the dogs that had a fast
weight loss rate (≥1% of BW per week) (for details
see Table S1).
In general, the GM of the dogs was dominated by
genera Fusobacterium (~20–50%) and Bacteroides
(~15–35%). A significant difference was seen in the
three genera Suterella, Fusobacterium and Mega-
monas between week 0 and week 6 as well as
between week 0 and week 12, when analysing the
results from both groups pooled together using an
ANOVA (P = 0.01, P = 0.02 and P = 0.03, respec-
tively, Table 1). However, none of the false discov-
ery rate (FDR) q-values are below 0.05. No
significant change was seen between 6 and 12 weeks.
To further elucidate if GM differences were related
to weight loss rate, the dogs were divided according
to weekly weight loss percentage. The dogs having
lost ≥1% bodyweight (BW) per week were classified
as having a fast weight loss rate, and the dogs having
lost <1% bodyweight (BW) per week classified as
having a slow weight loss rate. A decrease in Mega-
monas genus correlated (R2 = 0.68, P = 0.06) with
fast weight loss rate (≥1% per week) between week 0
and 6 (Fig. 1.). No correlation was found between
the weight loss rate and the changes in Suterella
(R = 0.10) and Fusobacterium (R = 0.24) genera.
The proportion of an unknown genus of the family
Ruminococcaceae was significantly lower in the dogs
with a fast weight loss rate (P = 0.02, q = 0.92) at
12 weeks. No significant differences were found in
any relative abundance of the identified genera of
the GM when comparing the fast and slow weight
loss rate dogs at either week 0 or at week 6.
For nine of the 12 dogs sufficient faecal material
remained post-sequencing to analyse the faecal
SCFA content of paired samples from week 0 and 6.
Table 2. The three most significant differences comparing the gut
microbiota (GM), as relative abundance OTUs at genus level,
between fast weight loss rate (≥1% of body weight per week) and
slow weight loss rate (<1.0% bodyweight per week) dogs at three
time points, week 0, week 6 and week 12, from dogs (n = 11) dur-
ing a 12 week weight loss trial (data was analysed using ANOVA,
P < 0.05, in bold, was considered a significant change)
Bacterial genus* P-
value
False
discovery
rate q-value
GM Week 0 Streptococcus spp. 0.14 4.76
Catenibacterium spp. 0.16 2.71
Unknown
(Ruminococcaceae spp.)
0.19 2.14
Week 6 Helicobacter spp. 0.06 2.49
Campylobacter spp. 0.07 1.36
Unknown
(Clostridiaceae spp.)
0.09 1.32
Week 12 Unknown
(Ruminococcaceae spp.)
0.02 0.92
*if unknown genus, (family).
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From the remaining three dogs, adequate faecal
material was left to perform the SCFA analyses for
1 week 6 sample from 1 of the dogs and 2 week 12
samples from the other two dogs. The faecal amount
of acetic acid was significantly lower at 6 weeks
(Table 4, P = 0.04) in the dogs with a fast weight loss
rate compared to the dogs with a slow weight loss
rate. There was also a tendency towards lower propi-
onic acid at 6 weeks in the dogs with a fast weight
loss rate compared to the dogs with a slow weight
loss rate (Table 4, P = 0.05). There were no signifi-
cant differences in the faecal short chain fatty acid
content at week 0 between the dogs with a fast com-
pared to slow weight loss rate. When plotting the
third and fourth principal components of the PCA,
including GM proportions and SCFA data at week 0
and 6 as well as the SCFA data, the dogs with a fast
weight loss rate at week 6 seemed to visually cluster
together (Fig. S3). However, weight loss rate was not
a significant factor for the third (PC3) or fourth
(PC4) principal components when analysed using an
ANOVA (P > 0.1). Plotting of the first and second
principal component did not yield any clustering
related to the weight loss rate (results not shown).
Discussion
In this study, we show that weight loss on a purpose-
made weight loss diet seems to affect the GM in dogs
independent of inclusion of moderate physical activ-
ity. Whether this difference is due to diet change or
weight loss per se is difficult to determine from our
study. Although all the dogs were fed the same diet,
we were still able to identify a correlation between
weight loss rate and the GM composition and faecal
Table 3. Group (exercise and diet (FD) or diet only (DO)), breed, age, sex and neutering (female entire (FE), female neutered (FN), male
entire (ME) and male neutered (MN)), body composition and weight loss rate, for dogs (n = 12) undergoing a 12-week weight loss intervention
including groups
Group Breed Age, years Sex and
neutering
BCS 1–9 week
0/week 12
BF% week
0/week 12
WL rate week
0–6 (%/week)
WL rate week
6–12 (%/week)
FD Labrador retriever 8.2 FE 7/6 51/43 6 7
FD Labrador retriever 7.0 FN 7/5 46/37 3.6 9.2
DO Basset Griffon Vendeen 6.7 FE 7/7 61/57 5.1 7
FD Berner Sennen 5.6 FN 8/7 67/53 8.5 7.5
DO Labrador retriever 6.2 MN 8/8 55/51 3.6 4.6
FD Australian Shepherd 10.0 FN 7/6 53/45 4.9 12.2
FD Australian Shepherd 3.0 FN 7/7 53/46 2.9 9.5
DO Nova Scotia Duck Tolling Retriever 8.9 FN 8/7 52/43 10.2 6
DO Mixed breed 5.5 FN 8/6 50/41 11.3 6.5
DO Labrador retriever 3.6 ME 6/5 35/30 9.1 1.3
DO Labrador retriever 8.5 MN 7/6 51/45 4.2 5.7
FD Mixed breed 6.9 FN 7/6 55/43 6.9 6.1
Body Condition Score (BCS) on a scale from 1 to 9, and body fat percentage (BF%) from week 0 and 12, previously included in Vitger
et al. (2016). Weekly weight loss in percentage of body weight from week 0 to week 6 (WL rate week 0–6), weekly weight loss in percent-
age of body weight from week 6 to end of trial (WL rate week 6–12).
Fig. 1. Correlation between the change in the Megamonas genus
between week 0 and week 6 (y-axis) and the weight loss rate in per-
centage per week (x-axis), in dogs (n = 8) undergoing a 12 week
weight loss trial.
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SCFA. A near-significant correlation was found
between a decrease in Megamonas spp. between
week 0 and 6, and a fast weight loss rate. In addition,
the proportion of an unknown genus of the family
Ruminococcaceae was found to be significantly
lower in dogs with a fast weight loss rate at 12 weeks.
However, even though the unknown genus of the
family Ruminococcaceae was significantly lower in
dogs with a fast weight loss rate, the FDR q-value
was not low, which could be related to lack of power
or that the result is a type 1 error. Interestingly, the
faecal acetic acid level was also lower at 6 weeks,
and in addition, a tendency towards lower propionic
acid at 6 weeks was seen in the dogs with a fast
weight loss rate. Members of Megamonas and
Ruminococcaceae are known to produce acetic and
propionic acid. The importance of a reduction in the
Megamonas genus and an unknown genus of the
Ruminococcaceae in weight loss rate is therefore
supported by a simultaneous reduction in acetic and
propionic acid. This indicates that for some over-
weight dogs a reduction in Megamonas and
Ruminococcaceae occurred, which then may have
led to a decrease in certain SCFA, leading to a more
expedient weight loss in these dogs. When comparing
the distribution of group (FD vs. DO), breed, age,
sex and neutering status, we found no difference in
the distribution between these factors relating to fast
compared to slow weight loss rate (Table S1). The
daily amount fed to the dogs during the study was
based on a 55% reduction in maintenance energy
requirement, which has been used in previous studies
(German et al. 2007). Because the amount to be fed
to each dog was solely based on giving 55% of their
estimated MER, the degree of energy restriction in
relation to previous feeding level was not necessarily
the same for all included dogs; this could be a possi-
ble confounder of the changes in GM composition
and metabolites related to weight loss rate. Similarly,
differences in composition of the study diet both in
macro- and micro nutrient content compared to the
diets given to the dogs previous to inclusion may also
have been a confounding factor. Furthermore,
between week 6 and 12 most of the dogs were either
fed less than the 55% of their estimated MER (five
dogs) or fed to maintain optimal bodyweight (two
dogs), which may have influenced the result regard-
ing the proportion of Ruminococcaceae found to be
lower in the dogs with a fast weight loss rate at
12 weeks.
Another limitation of this study is that the exact
timing of antibiotic and or deworming treatment
prior to study inclusion, or whether or not the dogs
had ever received antibiotics at all is unknown, and
Table 4. Faecal short chain fatty acid levels (mean  SD) in week 0 and 6 in dogs (n = 12) undergoing a 12 week weight loss trial, comparing
dogs with a fast (≥1% of body weight per week) and slow (<1.0% bodyweight per week) weight loss rate
SCFA Fast Slow P-value* 95% CI
Faecal SCFA Week 0 Acetic acid 70.2  27.4 64.7  22.3 0.75 40.1 to 29.1
Propionic acid 44.0  21.4 28.2  10.2 0.22 39.5 to 7.99
Isobutyric acid 1.01  0.56 0.81  0.7 0.65 1.05 to 0.65
n-Butyric acid 10.6  4.1 9.8  2.1 0.68 5.38 to 3.88
Iso-valeric acid 0.74  0.42 0.62  0.6 0.71 0.81 to 0.55
n-Valeric acid 0.28  0.23 0.29  0.29 0.97 0.35 to 0.36
DL-Lactic acid 0.41  1.0 0.00  0 0.34 1.44 to 0.62
Succinic acid 13.1  19.6 11.4  25.4 0.89 32.4 to 29.0
Week 6 Acetic acid 54.3  2.9 71.5  15.9 0.04 0.48 to 33.8
Propionic acid 23.2  4.0 32.7  7.78 0.05 0.43 to 18.5
Isobutyric acid 1.3  0.49 1.22  0.76 0.77 1.05 to 0.81
n-Butyric acid 8.2  1.4 10.5  3.78 0.24 1.89 to 6.45
Iso-valeric acid 1.2  0.57 1.03  0.63 0.57 1.06 to 0.68
n-Valeric acid 0.19  0.17 1.13  1.83 0.10 0.96 to 2.83
Succinic acid 1.3  4.0 1.31  2.93 0.85 5.60 to 4.64
Data was analysed using ANOVA, and reported as mean  SD, P < 0.05, in bold, was considered a significant change). *Adjusted P-value.
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this may potentially have influenced the results. Sim-
ilarly, even though the owners were asked to only
feed the test diet during the 12 weeks, a few devia-
tions were reported, and additional deviations may
have occurred, which could also have influenced the
results. Furthermore, the study period was limited to
12 weeks, and therefore several dogs had not
reached their optimal weight at the end of the study.
In human weight loss studies, it is common that
patients do not reach optimal weight during the
study periods but “only” manage to achieve a moder-
ate weight reduction. However, even a moderate
weight loss of 5 to 10% improves metabolic health
significantly (Soleymani et al. 2016). In addition, how
samples are collected and handled, which variable
region of the 16S rRNA gene is analysed, and
sequencing technique used, etc., have previously
been shown to influence GM results (Cruaud et al.
2014). This is a well-known limitation that hinders
direct comparison of results between studies of the
gut microbiota. However, a strength of this study is
that the faecal samples were collected per rectum
and subsequently immediately frozen at 80°C. Fur-
thermore, GM characterization was carried out using
a well-established and documented workflow.
Obese humans have been shown to have a GM
with a seemingly increased capacity for harvesting
energy from their diet compared to lean humans
(Turnbaugh et al. 2006). The tendency towards a cor-
relation of a decrease in the genus Megamonas, and
a lower proportion of Ruminococcaceae in addition
to the decrease in acetic and propionic acid, could
suggest that the difference in the dogs’ rate of weight
loss may relate to extraction of energy through colo-
nic fermentation of fermentable carbohydrates. This
is in consistent with studies in humans, which indi-
cate that obese individuals may respond differently
to a weight loss diet depending on their GM compo-
sition (Santacruz et al. 2009; Cotillard et al. 2013).
Members of Megamonas and Ruminococcaceae
produce acetic and propionic acid, which in rodents
has been shown to be a substrate for lipogenesis and
cholesterol formation (Conterno et al. 2011). Fur-
thermore, obese humans and rodents also seem to
have an increased amount of faecal SCFA content
compared to lean individuals, and this difference
does not seem to be related to a decrease in absorp-
tion (Rahat-Rozenbloom et al. 2014). SCFAs are
thought to benefit the host by improving glucose
homeostasis and stimulating enterocyte differentia-
tion, but it should be noted that SCFAs such as
acetic acid also serve as an energy source for the host
(McNeil 1984).
In a comparison of the GM composition of 21
obese pet dogs to the GM composition of 22 lean
dogs, Handl et al. (2013) found that bacteria
belonging to the phylum Actinobacteria and the
genus Roseburia were more abundant amongst the
obese dogs compared to the lean. Some members
of the Roseburia genus are, similarly to some mem-
bers of the Megamonas and Ruminococcaceae, rec-
ognized as producers of SCFAs with fermentable
fibres as the substrate (Rıos-Covian et al. 2016).
SCFA-producing bacteria may therefore be more
abundant in some obese dogs compared to lean
dogs, and our results indicate that SCFA produc-
tion may be important for the weight loss rate in
diet-induced weight loss in dogs. However, the sam-
ple size of this study was small (n = 12), and the
presented results should therefore be interpreted
with caution.
The lack of association between GM composition
and exercise could be due to the study population
being too small. Alternatively, the amount or fre-
quency of exercise was not sufficient to significantly
impact GM composition in this population of over-
weight pet dogs. Clarke et al. found differences in the
GM composition between professional rugby players
and two groups of controls, one with body mass index
(BMI) ≤25 and one of >28. However, they also found
that the dietary habits differed greatly between the
athletes and the controls and that the estimated diet-
ary protein content was related to the GM differences
detected (Clarke et al. 2014). This could be another
explanation for why no difference was found between
the FD and DO group in this study.
In summary, a sub-population of overweight and
obese dogs seems to have a GM composition that
could make them more resistant to weight loss, an
effect which may be related to an increased ability to
harvest energy from the diet through production of
SCFA. This finding should be confirmed in a larger
© 2017 The Authors. Veterinary Medicine and Science Published by John Wiley & Sons Ltd
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study of pet dogs, as well as colony dogs, living in a
controlled environment, to assess if these alterations
in GM impact long-term weight loss success and to
clarify possible underlying mechanisms.
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Figure S1. Flowchart illustrating inclusion and exclu-
sion of dogs, undergoing a 12 week weight loss trial,
and samples from the dogs collected at three time
points (week 0, week 6 and week 12) used in the
bioinformatics and statistical analysis, shown accord-
ing to which group (exercise and diet (FD) or diet
only (DO)) the dogs were included in.
Figure S2. Principal Coordinates Analysis (PCoA)
plot based on weighted UniFrac distance metrics of
the gut microbiome, as rarefied, relative abundance
OTUs at genus level, of dogs undergoing a 12 week
weight loss trial. The first three principal coordinates
(PCo1-3) are shown, comparing the group with a fast
weight loss (WL) rate (≥1% of body weight per
week, red points), and slow WL rate (<1% of body
weight per week, blue points) between week 0 and
week 6 (data was analysed with ANOSIM, P < 0.05
was considered a significant change).
Figure S3. Plot of the third (PC3) and fourth (PC4)
principal components of the fast WL rate group
(≥1% of body weight per week) and slow WL rate
group (<1% of body weight per week) between week
0 and week 6. The Principal Component Analysis
was conducted using the gut microbiome (rarefied,
relative abundance OTUs) data and the short chain
fatty acid (SCFA) data, from dogs (n = 11) undergo-
ing a 12 week weight loss trial.
Table S1. Distribution of group (exercise and diet
(FD, n = 6), or diet only (DO, n = 5)), breed, age,
sex and neutering status of dogs undergoing a
12 week weight loss trial. Dogs are grouped based
on whether they had a fast weight loss rate (≥1%
weight loss per week) or a slow weight loss rate
(<1% weight loss per week) between week 0 and
week 6.
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